HEADER TRANSFERASE 25-MAY-22 7ZYR TITLE COMPOUND 20 BOUND TO CK2ALPHA COMPND MOL_ID: 1; COMPND 2 MOLECULE: CASEIN KINASE II SUBUNIT ALPHA; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: CK II ALPHA; COMPND 5 EC: 2.7.11.1; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CSNK2A1, CK2A1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS FRAGMENT BASED DRUG DISCOVERY, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR P.BREAR,M.HYVONEN REVDAT 3 31-JAN-24 7ZYR 1 REMARK REVDAT 2 07-DEC-22 7ZYR 1 JRNL REVDAT 1 12-OCT-22 7ZYR 0 JRNL AUTH P.BREAR,C.DE FUSCO,E.L.ATKINSON,J.IEGRE,N.J.FRANCIS-NEWTON, JRNL AUTH 2 A.R.VENKITARAMAN,M.HYVONEN,D.R.SPRING JRNL TITL A FRAGMENT-BASED APPROACH LEADING TO THE DISCOVERY OF JRNL TITL 2 INHIBITORS OF CK2 ALPHA WITH A NOVEL MECHANISM OF ACTION. JRNL REF RSC MED CHEM V. 13 1420 2022 JRNL REFN ESSN 2632-8682 JRNL PMID 36426237 JRNL DOI 10.1039/D2MD00161F REMARK 2 REMARK 2 RESOLUTION. 1.85 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.10.1 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.85 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 22.17 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 26875 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.170 REMARK 3 R VALUE (WORKING SET) : 0.167 REMARK 3 FREE R VALUE : 0.209 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.040 REMARK 3 FREE R VALUE TEST SET COUNT : 1355 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 13 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.85 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.93 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.99 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2987 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2099 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2831 REMARK 3 BIN R VALUE (WORKING SET) : 0.2065 REMARK 3 BIN FREE R VALUE : 0.2788 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.22 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 156 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2748 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 63 REMARK 3 SOLVENT ATOMS : 265 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 14.64 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 16.49 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.23300 REMARK 3 B22 (A**2) : 0.73220 REMARK 3 B33 (A**2) : -0.96520 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.08940 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.183 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.151 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.134 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.145 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.132 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.946 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.923 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2975 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 4049 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1045 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 74 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 469 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2975 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 359 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 3601 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 0.93 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.28 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 15.94 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7ZYR COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 25-MAY-22. REMARK 100 THE DEPOSITION ID IS D_1292123329. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-AUG-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : SEALED TUBE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : BRUKER IMUS MICROFOCUS REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : BRUKER PLATINUM 135 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : PROTEUM PLUS REMARK 200 DATA SCALING SOFTWARE : PROTEUM PLUS 2013/3 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 26904 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.850 REMARK 200 RESOLUTION RANGE LOW (A) : 36.100 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 4.160 REMARK 200 R MERGE (I) : 0.10690 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.7700 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.85 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.88 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 2.83 REMARK 200 R MERGE FOR SHELL (I) : 0.45870 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.980 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5MOH REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 39.15 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.02 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 112.5MM MES PH 6.5, 35% GLYCEROL REMARK 280 ETHOXYLATE, 180 MM AMMONIUM ACETATE, VAPOR DIFFUSION, SITTING REMARK 280 DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 22.87800 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1610 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15400 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 610 O HOH A 687 2.08 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 CB ALA A 75 ND1 HIS A 236 25415 1.90 REMARK 500 OH TYR A 12 CG2 THR A 326 26416 1.99 REMARK 500 O HOH A 741 O HOH A 750 26416 2.11 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 73 -75.22 -84.62 REMARK 500 ASP A 156 41.66 -150.00 REMARK 500 ASP A 175 75.81 54.52 REMARK 500 ALA A 193 155.14 66.11 REMARK 500 ASP A 210 -158.67 -149.31 REMARK 500 HIS A 234 70.67 -101.49 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 765 DISTANCE = 7.18 ANGSTROMS REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 KF6 A 406 DBREF 7ZYR A 2 329 UNP P68400 CSK21_HUMAN 2 329 SEQADV 7ZYR SER A 21 UNP P68400 ARG 21 ENGINEERED MUTATION SEQADV 7ZYR ALA A 74 UNP P68400 LYS 74 ENGINEERED MUTATION SEQADV 7ZYR ALA A 75 UNP P68400 LYS 75 ENGINEERED MUTATION SEQADV 7ZYR ALA A 76 UNP P68400 LYS 76 ENGINEERED MUTATION SEQRES 1 A 328 SER GLY PRO VAL PRO SER ARG ALA ARG VAL TYR THR ASP SEQRES 2 A 328 VAL ASN THR HIS ARG PRO SER GLU TYR TRP ASP TYR GLU SEQRES 3 A 328 SER HIS VAL VAL GLU TRP GLY ASN GLN ASP ASP TYR GLN SEQRES 4 A 328 LEU VAL ARG LYS LEU GLY ARG GLY LYS TYR SER GLU VAL SEQRES 5 A 328 PHE GLU ALA ILE ASN ILE THR ASN ASN GLU LYS VAL VAL SEQRES 6 A 328 VAL LYS ILE LEU LYS PRO VAL ALA ALA ALA LYS ILE LYS SEQRES 7 A 328 ARG GLU ILE LYS ILE LEU GLU ASN LEU ARG GLY GLY PRO SEQRES 8 A 328 ASN ILE ILE THR LEU ALA ASP ILE VAL LYS ASP PRO VAL SEQRES 9 A 328 SER ARG THR PRO ALA LEU VAL PHE GLU HIS VAL ASN ASN SEQRES 10 A 328 THR ASP PHE LYS GLN LEU TYR GLN THR LEU THR ASP TYR SEQRES 11 A 328 ASP ILE ARG PHE TYR MET TYR GLU ILE LEU LYS ALA LEU SEQRES 12 A 328 ASP TYR CYS HIS SER MET GLY ILE MET HIS ARG ASP VAL SEQRES 13 A 328 LYS PRO HIS ASN VAL MET ILE ASP HIS GLU HIS ARG LYS SEQRES 14 A 328 LEU ARG LEU ILE ASP TRP GLY LEU ALA GLU PHE TYR HIS SEQRES 15 A 328 PRO GLY GLN GLU TYR ASN VAL ARG VAL ALA SER ARG TYR SEQRES 16 A 328 PHE LYS GLY PRO GLU LEU LEU VAL ASP TYR GLN MET TYR SEQRES 17 A 328 ASP TYR SER LEU ASP MET TRP SER LEU GLY CYS MET LEU SEQRES 18 A 328 ALA SER MET ILE PHE ARG LYS GLU PRO PHE PHE HIS GLY SEQRES 19 A 328 HIS ASP ASN TYR ASP GLN LEU VAL ARG ILE ALA LYS VAL SEQRES 20 A 328 LEU GLY THR GLU ASP LEU TYR ASP TYR ILE ASP LYS TYR SEQRES 21 A 328 ASN ILE GLU LEU ASP PRO ARG PHE ASN ASP ILE LEU GLY SEQRES 22 A 328 ARG HIS SER ARG LYS ARG TRP GLU ARG PHE VAL HIS SER SEQRES 23 A 328 GLU ASN GLN HIS LEU VAL SER PRO GLU ALA LEU ASP PHE SEQRES 24 A 328 LEU ASP LYS LEU LEU ARG TYR ASP HIS GLN SER ARG LEU SEQRES 25 A 328 THR ALA ARG GLU ALA MET GLU HIS PRO TYR PHE TYR THR SEQRES 26 A 328 VAL VAL LYS HET ATP A 401 31 HET ACT A 402 4 HET ACT A 403 4 HET ACT A 404 4 HET ACT A 405 4 HET KF6 A 406 16 HETNAM ATP ADENOSINE-5'-TRIPHOSPHATE HETNAM ACT ACETATE ION HETNAM KF6 5-BROMANYL-6-CHLORANYL-3-(1~{H}-PYRROL-2-YLMETHYL)- HETNAM 2 KF6 1~{H}-INDOLE FORMUL 2 ATP C10 H16 N5 O13 P3 FORMUL 3 ACT 4(C2 H3 O2 1-) FORMUL 7 KF6 C13 H10 BR CL N2 FORMUL 8 HOH *265(H2 O) HELIX 1 AA1 ASP A 14 ARG A 19 1 6 HELIX 2 AA2 PRO A 20 ASP A 25 1 6 HELIX 3 AA3 TYR A 26 HIS A 29 5 4 HELIX 4 AA4 ASN A 35 ASP A 37 5 3 HELIX 5 AA5 ALA A 74 ARG A 89 1 16 HELIX 6 AA6 ASP A 120 LEU A 128 1 9 HELIX 7 AA7 THR A 129 MET A 150 1 22 HELIX 8 AA8 LYS A 158 HIS A 160 5 3 HELIX 9 AA9 SER A 194 LYS A 198 5 5 HELIX 10 AB1 GLY A 199 VAL A 204 1 6 HELIX 11 AB2 TYR A 211 ARG A 228 1 18 HELIX 12 AB3 ASP A 237 GLY A 250 1 14 HELIX 13 AB4 GLY A 250 ASN A 262 1 13 HELIX 14 AB5 ASP A 266 ILE A 272 5 7 HELIX 15 AB6 ARG A 280 VAL A 285 5 6 HELIX 16 AB7 ASN A 289 VAL A 293 5 5 HELIX 17 AB8 SER A 294 LEU A 305 1 12 HELIX 18 AB9 ASP A 308 ARG A 312 5 5 HELIX 19 AC1 THR A 314 GLU A 320 1 7 HELIX 20 AC2 HIS A 321 TYR A 325 5 5 SHEET 1 AA1 5 TYR A 39 ARG A 47 0 SHEET 2 AA1 5 SER A 51 ASN A 58 -1 O VAL A 53 N GLY A 46 SHEET 3 AA1 5 LYS A 64 LEU A 70 -1 O VAL A 67 N PHE A 54 SHEET 4 AA1 5 PRO A 109 GLU A 114 -1 O LEU A 111 N LYS A 68 SHEET 5 AA1 5 LEU A 97 LYS A 102 -1 N ASP A 99 O VAL A 112 SHEET 1 AA2 2 ILE A 152 MET A 153 0 SHEET 2 AA2 2 GLU A 180 PHE A 181 -1 O GLU A 180 N MET A 153 SHEET 1 AA3 2 VAL A 162 ASP A 165 0 SHEET 2 AA3 2 LYS A 170 LEU A 173 -1 O LYS A 170 N ASP A 165 CISPEP 1 GLU A 230 PRO A 231 0 -5.93 CRYST1 58.721 45.756 63.204 90.00 111.68 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017030 0.000000 0.006770 0.00000 SCALE2 0.000000 0.021855 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017026 0.00000